Table of Contents

company-logo

Cyxone AB (publ), a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis, multiple sclerosis, and treatments for virally induced acute respiratory disorders. Its development portfolio comprises Rabeximod in a clinical Phase II program for rheumatoid arthritis and Covid-19 infections; and T20K, a Phase 1 candidate drug for the treatment of multiple sclerosis. The company was incorporated in 2015 and is based in Malmö, Sweden.

Cyxone Dividend Announcement

• Cyxone does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Cyxone dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Cyxone Dividend History

Cyxone Dividend Yield

Cyxone current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Cyxone stock? Use our calculator to estimate your expected dividend yield:

Cyxone Financial Ratios

P/E ratio-0.20
PEG ratio0.00
P/B ratio0.14
ROE-64.26%
Payout ratio0.00%
Current ratio2.02
Quick ratio2.02
Cash Ratio1.82

Cyxone Dividend FAQ

Does Cyxone stock pay dividends?
Cyxone does not currently pay dividends to its shareholders.
Has Cyxone ever paid a dividend?
No, Cyxone has no a history of paying dividends to its shareholders. Cyxone is not known for its dividend payments.
Why doesn't Cyxone pay dividends?
There are several potential reasons why Cyxone would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Cyxone ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Cyxone has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Cyxone a dividend aristocrat?
Cyxone is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Cyxone a dividend king?
Cyxone is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Cyxone a dividend stock?
No, Cyxone is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Cyxone stocks?
To buy Cyxone you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Cyxone stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.